Poolbeg Pharma signs deal with AI company on influenza data
Project could yield new and better treatments for disease
Poolbeg Pharma agrees option agreement with UCD
Company signs licence for MelioVac, a pre-clinical vaccine for melioidosis
Open Orphan spin-out Poolbeg Pharma to list on London market
Company will use money from listing to meet costs for flu drug trials, develop assets
Blocking the immune system aims to improve kidney transplants success rate
Opsona Therapeutics tests immune-dampening to ward of dangerous inflamation after transplants. Claire O’Connell finds out about the science behind it
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices